US Stock MarketDetailed Quotes

NUV Nuveen Municipal Value Fund Inc

Watchlist
  • 8.900
  • +0.050+0.56%
Close Feb 28 16:00 ET
  • 8.900
  • 0.0000.00%
Post 16:00 ET
1.85BMarket Cap9.27P/E (TTM)

Nuveen Municipal Value Fund Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Oct 31, 2024
(Q4)Oct 31, 2024
(Q2)Apr 30, 2024
(FY)Oct 31, 2023
(Q4)Oct 31, 2023
(Q2)Apr 30, 2023
(FY)Oct 31, 2022
(Q4)Oct 31, 2022
(Q2)Apr 30, 2022
(FY)Oct 31, 2021
Assets
Cash cash equivalents and federal funds sold
--0
--0
--0
2,971.85%12.25M
2,971.85%12.25M
460.78%2.09M
-58.71%398.64K
--398.64K
--371.97K
--965.49K
-Cash and cash equivalents
--0
--0
--0
2,971.85%12.25M
2,971.85%12.25M
460.78%2.09M
-58.71%398.64K
--398.64K
--371.97K
--965.49K
-Restricted cash and investments
----
----
----
--0
--0
--0
--0
--0
--0
--0
Receivables
31.60%33.07M
31.60%33.07M
6.80%48.4M
-24.03%25.13M
-24.03%25.13M
45.62%45.32M
-30.87%33.08M
--33.08M
-40.41%31.12M
57.60%47.85M
-Available for sale securities
--11.25M
--11.25M
--26.47M
----
----
----
----
----
----
----
Derivative assets
----
----
--0
----
----
----
----
----
----
----
Deferred costs
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Other assets
-59.90%196.53K
-59.90%196.53K
-55.81%216.3K
16.10%490.16K
16.10%490.16K
0.66%489.49K
-15.46%422.21K
--422.21K
8.21%486.27K
28.12%499.44K
Total assets
9.65%2.01B
9.65%2.01B
0.21%1.97B
-0.87%1.83B
-0.87%1.83B
-1.50%1.97B
-17.71%1.85B
--1.85B
-12.04%2B
1.50%2.25B
Liabilities
Payables
518.14%35.01M
518.14%35.01M
81.04%15.86M
-14.83%5.66M
-14.83%5.66M
62.61%8.76M
-46.29%6.65M
--6.65M
-71.18%5.39M
9.50%12.38M
-Accounts payable
492.32%33.55M
492.32%33.55M
72.84%15.14M
-14.83%5.66M
-14.83%5.66M
62.61%8.76M
-46.29%6.65M
--6.65M
-71.18%5.39M
9.50%12.38M
-Total tax payable
--716.55K
--716.55K
----
----
----
----
----
----
----
----
-Other payable
--745.98K
--745.98K
--718.45K
----
----
----
----
----
----
----
Long term debt and capital lease obligation
--6.82M
--6.82M
--12.26M
----
----
----
----
----
----
----
Total liabilities
178.58%79.77M
178.58%79.77M
82.87%58.06M
-3.52%28.63M
-3.52%28.63M
11.41%31.75M
-32.38%29.68M
--29.68M
-45.59%28.5M
2.50%43.9M
Shareholders'equity
Share capital
0.00%2.08M
0.00%2.08M
0.00%2.08M
0.00%2.08M
0.00%2.08M
0.00%2.08M
0.02%2.08M
--2.08M
0.11%2.08M
0.21%2.08M
-common stock
0.00%2.08M
0.00%2.08M
0.00%2.08M
0.00%2.08M
0.00%2.08M
0.00%2.08M
0.02%2.08M
--2.08M
0.11%2.08M
0.21%2.08M
Paid-in capital
0.00%1.96B
0.00%1.96B
0.00%1.96B
0.00%1.96B
0.00%1.96B
0.00%1.96B
0.02%1.96B
--1.96B
0.13%1.96B
0.24%1.96B
Retained earnings
78.04%-35.39M
78.04%-35.39M
-80.11%-49.95M
-10.26%-161.17M
-10.26%-161.17M
-600.97%-27.74M
-161.44%-146.17M
---146.17M
-97.85%5.54M
13.00%237.9M
Total stockholders'equity
6.97%1.93B
6.97%1.93B
-1.15%1.92B
-0.82%1.8B
-0.82%1.8B
-1.69%1.94B
-17.42%1.82B
--1.82B
-11.25%1.97B
1.48%2.2B
Total equity
6.97%1.93B
6.97%1.93B
-1.15%1.92B
-0.82%1.8B
-0.82%1.8B
-1.69%1.94B
-17.42%1.82B
--1.82B
-11.25%1.97B
1.48%2.2B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
Unqualified Opinion
--
--
Unqualified Opinion
--
--
Unqualified Opinion
(FY)Oct 31, 2024(Q4)Oct 31, 2024(Q2)Apr 30, 2024(FY)Oct 31, 2023(Q4)Oct 31, 2023(Q2)Apr 30, 2023(FY)Oct 31, 2022(Q4)Oct 31, 2022(Q2)Apr 30, 2022(FY)Oct 31, 2021
Assets
Cash cash equivalents and federal funds sold --0--0--02,971.85%12.25M2,971.85%12.25M460.78%2.09M-58.71%398.64K--398.64K--371.97K--965.49K
-Cash and cash equivalents --0--0--02,971.85%12.25M2,971.85%12.25M460.78%2.09M-58.71%398.64K--398.64K--371.97K--965.49K
-Restricted cash and investments --------------0--0--0--0--0--0--0
Receivables 31.60%33.07M31.60%33.07M6.80%48.4M-24.03%25.13M-24.03%25.13M45.62%45.32M-30.87%33.08M--33.08M-40.41%31.12M57.60%47.85M
-Available for sale securities --11.25M--11.25M--26.47M----------------------------
Derivative assets ----------0----------------------------
Deferred costs --0--0--0--0--0--0--0--0--0--0
Other assets -59.90%196.53K-59.90%196.53K-55.81%216.3K16.10%490.16K16.10%490.16K0.66%489.49K-15.46%422.21K--422.21K8.21%486.27K28.12%499.44K
Total assets 9.65%2.01B9.65%2.01B0.21%1.97B-0.87%1.83B-0.87%1.83B-1.50%1.97B-17.71%1.85B--1.85B-12.04%2B1.50%2.25B
Liabilities
Payables 518.14%35.01M518.14%35.01M81.04%15.86M-14.83%5.66M-14.83%5.66M62.61%8.76M-46.29%6.65M--6.65M-71.18%5.39M9.50%12.38M
-Accounts payable 492.32%33.55M492.32%33.55M72.84%15.14M-14.83%5.66M-14.83%5.66M62.61%8.76M-46.29%6.65M--6.65M-71.18%5.39M9.50%12.38M
-Total tax payable --716.55K--716.55K--------------------------------
-Other payable --745.98K--745.98K--718.45K----------------------------
Long term debt and capital lease obligation --6.82M--6.82M--12.26M----------------------------
Total liabilities 178.58%79.77M178.58%79.77M82.87%58.06M-3.52%28.63M-3.52%28.63M11.41%31.75M-32.38%29.68M--29.68M-45.59%28.5M2.50%43.9M
Shareholders'equity
Share capital 0.00%2.08M0.00%2.08M0.00%2.08M0.00%2.08M0.00%2.08M0.00%2.08M0.02%2.08M--2.08M0.11%2.08M0.21%2.08M
-common stock 0.00%2.08M0.00%2.08M0.00%2.08M0.00%2.08M0.00%2.08M0.00%2.08M0.02%2.08M--2.08M0.11%2.08M0.21%2.08M
Paid-in capital 0.00%1.96B0.00%1.96B0.00%1.96B0.00%1.96B0.00%1.96B0.00%1.96B0.02%1.96B--1.96B0.13%1.96B0.24%1.96B
Retained earnings 78.04%-35.39M78.04%-35.39M-80.11%-49.95M-10.26%-161.17M-10.26%-161.17M-600.97%-27.74M-161.44%-146.17M---146.17M-97.85%5.54M13.00%237.9M
Total stockholders'equity 6.97%1.93B6.97%1.93B-1.15%1.92B-0.82%1.8B-0.82%1.8B-1.69%1.94B-17.42%1.82B--1.82B-11.25%1.97B1.48%2.2B
Total equity 6.97%1.93B6.97%1.93B-1.15%1.92B-0.82%1.8B-0.82%1.8B-1.69%1.94B-17.42%1.82B--1.82B-11.25%1.97B1.48%2.2B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion----Unqualified Opinion----Unqualified Opinion----Unqualified Opinion
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Cars.com
CARS
+9.73%
Lantheus
LNTH
+2.55%
Halozyme Therapeutics
HALO
+2.51%
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
+2.27%
Collegium Pharmaceutical
COLL
+2.22%

Unlock the Full List